MEDICAL DEVICES

Nagarro partners with BioT to deliver best-in-class software for medical devices

Nagarro | November 25, 2021

Nagarro partners with BioT to deliver best-in-class software for medical devices

Nagarro, a global digital engineering company, and BioT Medical, a No-code connected-care platform for medical devices, announced a strategic partnership. In an age of data-driven hyper-personalized care, maximizing the medical device potential has never been more critical. The Nagarro BioT partnership represents the best of two worlds, digital engineering excellence, and connected medical device mastery.

This partnership will allow device manufacturers to transform any medical device into a connected care platform within days and build an end-to-end personalized patient care system that is purposefully built for their needs and is fully integrated with the existing caregiver's ecosystem and workflows. Device manufacturers can now benefit from a direct-to-consumer relationship while providing caregivers with better care capabilities using their existing workflows. 

"Our partnership with Nagarro will help fuel both companies' continued innovation and growth efforts. Through our regulated connected care, no-code platform, BioT will enable Nagarro to easily and quickly expand their best-in-class digital health offerings to the broader healthcare market. Together we can deliver a new level of value for medical device manufacturers, their patients, and the entire healthcare ecosystem," says Daniel Adler, Co-Founder & CEO at BioT Medical. 

"Digital health ecosystems evolve every day, so do connected medical devices and Software as a Medical Device. The future will be for those who understand the value of connected data integrated into their SaaS solutions and creating personalized care experiences. We are very excited by what BioT is doing in the Life Sciences space. Together we represent that vision. We have a long history of developing Life Sciences solutions around the world and look forward to bringing even more complete and integrated solutions with this exciting partnership."

Andrei Doibani, Global Business Unit Head for Life Sciences and Healthcare at Nagarro

About BioT 

BioT is a medical-grade PaaS (Platform-as-a-service) that, for the first time, introduces a no-code approach to the regulated medical device space. It's a game-changing solution to get medical devices on the cloud in a snap using a template-based drag-and-drop approach, without losing precious time or investing huge development efforts and costs. BioT's Triple-C Connect-Collaborate-Care solution enables medical device manufacturers to securely connect devices to a medical-grade cloud, boost personalized engagement and improve health outcomes through collaboration between patients and caregivers, and turn data into actionable insights to improve clinical decision-making and care experiences. 

About Nagarro 

Nagarro, a global digital engineering leader, helps clients become innovative, digital-first companies and thus, win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its approach of "Thinking Breakthroughs". Nagarro employs over 10,000 people in 26 countries. 

Spotlight

rom the embrace of omni-channel experiences to the revision of physician alignment strategies, the following infographic captures our team's 2016 "What's Next" industry outlook:

Related News

FCC Added $198 Million To Its Rural Healthcare Program

Healthcare Dive | July 02, 2020

The Federal Communications Commission has added $198 million to its rural healthcare program, which helps providers deploy broadband healthcare networks, the agency said Tuesday.The unused funds from prior years are being carried forward to 2020. With the current funding cap at about $600 million, the total available for provider requests will be more than $800 million — the most in the program's history.In a statement, FCC Chairman Ajit Pai noted telehealth funding is especially important as the nation fights COVID-19 and use of virtual visits has skyrocketed. "Today's announcement speaks to the FCC's commitment to ensuring that rural health care providers can continue to serve their communities during the difficult time and well into the future.As states in the South and West become new COVID-19 hotspots, rural providers face great challenges in preparing for patient surges while also maintaining the ability to meet other needs of patients in their communities.

Read More

HEALTH TECHNOLOGY

FAST+ Solution of CitiusTech to Utilize IBM Cloud Paks to Support Upsurge Healthcare Interoperability

CitiusTech | February 17, 2021

A leading healthcare technology solutions and service provider company, CitiusTech, has announced its adoption of IBM Cloud Paks for powering its FAST+ solution to improve healthcare interoperability. FAST+ solution of CitiusTech is aimed at healthcare organizations’ FHIR-based solution to meet with different interoperability needs, which include Patient Access Rule and compliance to CMS’ Interoperability. From the solution, healthcare organizations get a strong platform for consent management, FHIR data repository, standardize information, and also allows real-time data access. “We are excited to spread our teamwork with IBM,” said SVP of Partnerships and Strategy at CitiusTech, Manish Sharma. “Our adoption of IBM’s open technology ecosystem pays for better scalability and tractability to our customer’s lasting interoperability requirements.” CitiusTech is a portion of IBM's cloud Pak ecosystem, an enterprise to support associates of all types to assist clients to accomplish and streamline workloads from bare-metal to multi-cloud with Red Hat OpenShift, the business's leading initiative Kubernetes platform. CitiusTech is powering Cloud Engagement Fund IBM, recognized as part of IBM's $1 billion assets into its ecosystem, to get technical resources and cloud acclaims to provision migration of client workloads to open hybrid cloud settings, such as IBM Cloud. By means of contributions from IBM Cloud, such as the IBM Kubernetes Service (IKS), the company can advance more value from its information to support speed the growth of new tools intended to improve competence for the manufacturing. The company has a sturdy digital innovation exercise that emphasizes helping customers assume enterprise-wide change creativities using IBM technology stages including IBM BigInsights, IBM Cloud Pak, IBM Netezza, IBM Unified Data Models, and IBM Cognos Analytics for Healthcare. About CitiusTech CitiusTech is a well-known technology for healthcare industry services and various solutions for health tech companies, payers, providers, and life sciences organizations. The company has around 4,000 professionals globally. CitiusTech allows healthcare groups to drive medical value chain superiority.

Read More

HEALTH TECHNOLOGY

iXensor’s Eveline·Care Telehealth Empowering Fertility Services to Assist Patients’ Conceptions With At-Home Test Monitoring

iXensor | September 14, 2021

iXensor, the pioneer of mobile health, launches its new Eveline•Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly appreciated by patients for comfortable at-home testing, especially amid the ongoing COVID-19 pandemic globally. Helping couples to conceive all around the world Aiming to help couples ease the stress of trying to conceive, iXensor develops Eveline, an AI-powered ovulation prediction kit based on its patented PixoTech® technology, transforming smartphones into at-home testing devices. Eveline leverages front cameras of smartphones to analyze luteinizing hormone (LH) test strips and inform current ovulation status with 99% accuracy. On top of that, the AI-powered Eveline App predicts up to 5 fertile days per menstruation cycle. Users are then conveniently reminded through personalized notifications, thus they never miss the peak time to get pregnant. What does Eveline•Care offer? Eveline•Care is a telehealth platform that enables fertility consultants to seamlessly access their patients' timely ovulation test data and recorded symptoms through a live dashboard presentation, including a hormone profile chart. Eveline users authorize participating fertility consultants to access their fertility data captured on the Eveline App. Such data includes their luteinizing hormone (LH) levels, basal body temperature (BBT), mood, diet, and daily symptoms. Eveline•Care allows physicians to monitor a patient's fertility condition in real-time remotely and provide comprehensive consultation. "Eveline•Care gives patients a better understanding of their hormonal patterns and makes the communication with doctors more straightforward. The feedback we are getting from patients is very encouraging," said Mei-Chao Hsu, M.D., Director at Sumay's Medical Clinic. How does Eveline•Care facilitate IUI? Another use case of Eveline•Care lies in supporting Intrauterine Insemination (IUI) treatments. For a successful IUI procedure, the timing is crucial. Once the LH surge happens, the participating physician is automatically notified through Eveline•Care platform and can invite the patient back to the clinic in time for the IUI procedure. This solution increases the chance of a successful IUI treatment by reducing the risk scenario that the patient ovulates earlier than expected. Attending doctor Yi-Pin Li commented on the service: "Eveline•Care platform empowers us to monitor IUI patients' hormonal levels frequently and remotely, so we can make sure they don't miss their critical timings in the IUI treatment. As a result, our patients feel confident knowing their doctors are always monitoring their status for IUI procedure and thereby ensuring a higher success rate." About iXensor iXensor, the pioneer of mobile health, turns smartphones into lab-grade mobile medical diagnostics. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world's first US FDA-approved smartphone camera-based blood test. Based on the PixoTech® platform, iXensor has ventured into at-home self-testing and clinical point-of-care diagnostics across infectious diseases, women's health, and cardiovascular diseases.

Read More

Spotlight

rom the embrace of omni-channel experiences to the revision of physician alignment strategies, the following infographic captures our team's 2016 "What's Next" industry outlook: